Summit Therapeutics Statistics

Total Valuation

SMMT has a market cap or net worth of $14.97 billion. The enterprise value is $14.62 billion.

Market Cap	14.97B
Enterprise Value	14.62B

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, before market open.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

SMMT has 742.67 million shares outstanding. The number of shares has increased by 3.86% in one year.

Current Share Class	742.67M
Shares Outstanding	742.67M
Shares Change (YoY)	+3.86%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	80.13%
Owned by Institutions (%)	13.31%
Float	116.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	43.42
P/TBV Ratio	43.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.63, with a Debt / Equity ratio of 0.02.

Current Ratio	10.63
Quick Ratio	10.36
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-42.31

Financial Efficiency

Return on equity (ROE) is -123.93% and return on invested capital (ROIC) is -58.34%.

Return on Equity (ROE)	-123.93%
Return on Assets (ROA)	-52.50%
Return on Invested Capital (ROIC)	-58.34%
Return on Capital Employed (ROCE)	-67.48%
Revenue Per Employee	n/a
Profits Per Employee	-$1.51M
Employee Count	159
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +155.19% in the last 52 weeks. The beta is -1.05, so SMMT's price volatility has been lower than the market average.

Beta (5Y)	-1.05
52-Week Price Change	+155.19%
50-Day Moving Average	23.49
200-Day Moving Average	20.80
Relative Strength Index (RSI)	44.19
Average Volume (20 Days)	5,151,426

Short Selling Information

Short Interest	24.44M
Short Previous Month	25.73M
Short % of Shares Out	20.95%
Short % of Float	n/a
Short Ratio (days to cover)	6.46

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-235.45M
Pretax Income	-161.69M
Net Income	-240.76M
EBITDA	-235.37M
EBIT	-235.45M
Earnings Per Share (EPS)	-$0.34

Full Income Statement

Balance Sheet

The company has $361.32 million in cash and $6.45 million in debt, giving a net cash position of $354.87 million or $0.48 per share.

Cash & Cash Equivalents	361.32M
Total Debt	6.45M
Net Cash	354.87M
Net Cash Per Share	$0.48
Equity (Book Value)	344.33M
Book Value Per Share	0.46
Working Capital	335.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$173.14 million and capital expenditures -$557,000, giving a free cash flow of -$173.70 million.

Operating Cash Flow	-173.14M
Capital Expenditures	-557,000
Free Cash Flow	-173.70M
FCF Per Share	-$0.23

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SMMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.86%
Shareholder Yield	-3.86%
Earnings Yield	-1.61%
FCF Yield	-1.16%

Dividend Details

Analyst Forecast

The average price target for SMMT is $34.73, which is 72.27% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$34.73
Price Target Difference	72.27%
Analyst Consensus	Strong Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2